HKEX Risk Disclosure Requirements for an Applicant's Use of Derivatives

The Hong Kong Stock Exchange (HKEX) has intensified its scrutiny of derivative usage among listing applicants, a shift driven by the increasing complexity of financial instruments deployed by pre-IPO companies and a series of high-profile valuation disputes in 2024-2025. This regulatory tightening is not a theoretical exercise. In the first half of 2025 alone, HKEX issued at least three return letters explicitly citing inadequate risk disclosures related to derivative instruments, forcing applicants to postpone their listing timetables. For CFOs and their sponsor teams, this means that a standard risk factor section in a prospectus (招股書) is no longer sufficient. The new expectation, codified in HKEX’s updated Listing Decision LD143-2024 and reinforced by SFC’s revised Code of Conduct for Sponsors (effective 1 January 2025), demands a granular, quantified, and scenario-based analysis of how derivatives impact an applicant’s financial position, operational cash flows, and overall business model. Failure to comply does not merely invite a round of follow-up questions; it can result in a formal rejection of the listing application or, post-listing, enforcement action under the Securities and Futures Ordinance (SFO, Cap. 571). This article dissects the specific disclosure requirements, the underlying regulatory rationale, and the practical steps applicants must take to navigate this evolving landscape.

The Regulatory Framework: From General Principle to Specific Mandate

The foundation of derivative risk disclosure for listing applicants rests on two interconnected regulatory pillars: the HKEX Listing Rules and the SFC’s regulatory toolkit. The shift from a principle-based approach to a prescriptive, data-driven mandate is the defining feature of the current environment.

HKEX Listing Rules and Guidance Letters

The primary source of obligation is Main Board Listing Rule 11.07, which requires a prospectus to contain “full, true and accurate disclosure” of all material information. The Exchange has historically interpreted this to include derivative exposures. However, the 2024-2025 period saw a material escalation in specificity. HKEX Listing Decision LD143-2024, published in December 2024, explicitly addressed the disclosure of convertible instruments with embedded derivatives, a common feature in pre-IPO financing rounds. The decision mandates that applicants must quantify the potential dilutive impact of conversion rights under at least three market scenarios: a 20% decline, a 10% increase, and a flat price scenario from the offer price. This is a direct response to the 2023 case of a biotech applicant whose prospectus failed to disclose that a convertible note’s conversion price reset mechanism could, under a moderate share price decline, dilute existing shareholders by over 45%. The Exchange deemed this omission a material deficiency, leading to the application’s withdrawal.

Beyond convertible instruments, the HKEX’s guidance on “structured products” held by applicants has also been updated. In a 2025 Q1 update to its “Guide for New Applicants,” the Exchange explicitly requires disclosure of any derivative instrument that has a notional value exceeding 10% of the applicant’s total assets at the time of the latest practicable date. This threshold is a bright-line test. For example, an applicant with HKD 500 million in total assets must disclose any derivative with a notional value above HKD 50 million, regardless of whether it is held for hedging or speculative purposes. The disclosure must include the instrument’s type, counterparty, maturity date, and a sensitivity analysis showing the impact of a 100-basis-point shift in the underlying reference rate.

SFC’s Code of Conduct for Sponsors

The SFC’s revised Code of Conduct for Sponsors, effective 1 January 2025, imposes a parallel, and arguably more stringent, duty on sponsors. Paragraph 17.6 of the Code now requires sponsors to “independently verify the valuation of any derivative instrument that is material to the applicant’s financial condition or business operations.” This moves beyond a simple review of the applicant’s internal models. The sponsor must engage a qualified third-party valuation expert to perform an independent assessment, unless the derivative is a plain-vanilla instrument traded on an exchange (e.g., a simple futures contract on the HKEX). The SFC has made clear that a sponsor’s reliance on an applicant’s internal valuation, even if prepared by a qualified team, is no longer acceptable for complex or bespoke derivatives.

The practical consequence of this requirement is significant. For a pre-IPO company with a portfolio of foreign exchange forwards, interest rate swaps, and commodity options, the sponsor’s due diligence timeline can extend by four to six weeks solely to accommodate the independent valuation process. The SFC has also indicated in its 2024 annual report that it will scrutinize sponsor work papers for evidence of this independent verification, and has already issued two fines in 2025 for failures in this area, each exceeding HKD 10 million.

Types of Derivatives and Their Specific Disclosure Requirements

The disclosure burden is not uniform across all derivative types. The HKEX and SFC have developed a tiered approach, with the most stringent requirements reserved for instruments that pose the greatest risk of material misstatement or unexpected loss.

Embedded Derivatives in Convertible Instruments

This category has become the single most contentious area in listing applications. Embedded derivatives, such as conversion options, price reset clauses, and redemption features in convertible bonds or preference shares, require a multi-layered disclosure. The applicant must provide a full term sheet of the instrument, including all triggering events for conversion or redemption. The scenario analysis required by LD143-2024 is the centerpiece. For each scenario (20% decline, 10% increase, flat), the applicant must calculate:

• The number of shares issuable upon conversion.
• The dilution percentage to existing shareholders.
• The impact on earnings per share (EPS) and net asset value (NAV) per share.

A 2024 case involving a mainland Chinese technology company illustrates the pitfalls. The applicant had issued a series of convertible notes to a strategic investor with a conversion price that adjusted downward if the company’s revenue fell below a certain threshold. The applicant’s initial prospectus only disclosed the basic conversion terms. The HKEX required a full scenario analysis, which revealed that under the 20% decline scenario, the conversion price would fall by 35%, resulting in a dilution of 62% to existing shareholders. This information was deemed material and had to be prominently featured in the risk factors section.

Foreign Exchange and Interest Rate Derivatives

For applicants with significant cross-border operations, foreign exchange (FX) forwards, swaps, and interest rate derivatives are common. The disclosure requirement here centers on the hedge accounting policy and the effectiveness of the hedging relationship. HKEX Listing Rule 14A.84, read in conjunction with HKAS 39 (or HKFRS 9 for newer applicants), requires a detailed explanation of the hedging strategy. The applicant must disclose:

• The notional amount of each derivative contract.
• The underlying exposure being hedged.
• The hedge ratio and the method used to assess hedge effectiveness.
• The potential impact of a 10% adverse movement in the relevant exchange rate or interest rate on the company’s profit or loss and equity.

A practical example involves a Hong Kong-listed logistics company with substantial revenue in USD and costs in RMB. The company used a series of one-month rolling FX forwards to hedge its USD/RMB exposure. In its 2024 listing application, the HKEX required the company to disclose not just the aggregate notional of the forwards, but also the specific counterparty concentration risk. The company’s forwards were all with a single, mid-tier Chinese bank. The Exchange required a risk factor explaining that a default by that counterparty could result in a material loss, and the company had to disclose the credit rating of the counterparty.

Commodity and Equity Derivatives

Applicants in the resources, energy, or agricultural sectors often use commodity derivatives to manage price risk. For equity derivatives, such as total return swaps or equity-linked notes, the disclosure requirements are equally demanding. The key principle is that the applicant must demonstrate that the derivative is used for hedging an underlying commercial exposure and not for speculative trading. The HKEX has a strong bias against speculative use of derivatives by listing applicants. If an applicant holds a derivative that is not clearly linked to a business risk, the Exchange will likely require a detailed explanation of the business rationale and a quantification of the speculative exposure.

In a 2023 case involving a mining company, the applicant held a portfolio of copper futures contracts. The company’s revenue was based on copper sales, so the futures were a legitimate hedge. However, the company also held a small position in gold futures, which was unrelated to its core business. The HKEX required the company to spin off or liquidate the gold futures position before listing, or to disclose it as a material speculative activity with a full sensitivity analysis. The company chose to liquidate the position.

Practical Implications for Applicants and Their Advisors

The enhanced disclosure requirements have direct, measurable consequences for the listing timeline, the cost of the exercise, and the structure of the pre-IPO balance sheet.

Impact on the Listing Timeline and Costs

The most immediate effect is the extension of the sponsor’s due diligence phase. The requirement for independent valuation of complex derivatives adds a minimum of four weeks to the process. For an applicant with multiple derivative instruments, the timeline can stretch to eight weeks. This translates directly into higher professional fees. A typical engagement for an independent valuation of a portfolio of FX forwards and interest rate swaps can cost between HKD 500,000 and HKD 1,500,000, depending on complexity. The sponsor’s own legal and due diligence costs also increase, as the legal team must draft the expanded risk factor sections and the sponsor must prepare a detailed work paper trail for the SFC.

Furthermore, the requirement to perform scenario analysis and sensitivity calculations means that the financial due diligence team must have access to robust financial models. Many pre-IPO companies, particularly those from the mainland, may not have the in-house capability to produce such models. This often necessitates the engagement of a specialist financial advisory firm, adding another layer of cost and time.

Structuring Pre-IPO Financing to Minimize Disclosure Burden

A proactive strategy for applicants is to structure pre-IPO financing rounds to minimize the use of derivatives or to simplify their terms. The most common approach is to use straight equity or simple convertible instruments without complex reset clauses or embedded options. For example, a simple convertible note with a fixed conversion price and a fixed maturity date is far easier to disclose than one with a price reset linked to revenue or EBITDA targets.

Another strategy is to terminate or novate complex derivative positions before filing the A1 application. This eliminates the need for disclosure entirely, provided the termination is done at arm’s length and does not trigger a material loss. For example, an applicant with a bespoke total return swap can negotiate with its counterparty to close out the position, paying a termination fee if necessary. This approach, while potentially incurring a one-time cost, avoids the disclosure risk and the associated due diligence costs.

The Role of the Audit Committee and Internal Controls

The SFC’s Code of Conduct for Sponsors implicitly requires that the applicant’s own internal controls over derivative risk management be robust. The sponsor must assess the applicant’s ability to monitor, measure, and report derivative exposures. This means that the applicant’s audit committee must have a documented policy for derivative use, including approval limits, counterparty credit risk limits, and a process for regular valuation. The internal audit function must have the capability to independently verify the valuations.

A 2024 enforcement case by the SFC against a listed company’s former CFO highlighted the consequences of weak internal controls. The company had entered into a series of interest rate swaps without proper board approval, and the internal audit function had not flagged the issue. The SFC fined the CFO HKD 5 million and disqualified him from acting as a director for three years. For a pre-IPO applicant, such a deficiency would be a material red flag for the Exchange.

Actionable Takeaways for Listing Applicants

1. Commission an independent valuation of all material derivatives at least 12 weeks before the intended A1 filing date, ensuring the valuation report addresses the scenario analysis requirements of HKEX Listing Decision LD143-2024.
2. Prepare a detailed sensitivity analysis for each derivative instrument, showing the impact on EPS, NAV, and cash flow under the three mandated market scenarios (20% decline, 10% increase, and flat).
3. Review all pre-IPO financing instruments for embedded derivatives, and if present, prepare a full term sheet and a dilution analysis that quantifies the worst-case scenario for existing shareholders.
4. Establish a formal derivative risk management policy approved by the board, including counterparty credit limits and a process for independent price verification, to satisfy the sponsor’s due diligence requirements.
5. Consider simplifying or terminating complex derivative positions before the listing application, as the cost of disclosure and the risk of regulatory rejection often outweigh the benefits of maintaining the position.